During the two past decades, atrial fibrillation (AF) has become a major public health problem. With 33.5 million patients worldwide, AF is the most common arrhythmia in adults. Accordingly, the $ 4.9 Bn AF device market is growing at 15.6% CAGR. Building upon 15+ years of research, Volta Medical has investigated a therapeutic product using data-driven AI approach for optimal real-time guidance during atrial fibrillation (AF) interventions. Our product has the potential to revolutionize AF interventions in drastically improving both procedural workflow and clinical outcomes. Notably, Volta’s product has been tested clinically with extremely promising results. Our first product is entirely ready for approval and does not need further development.
Total Funding: $3,150,000
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2016
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Volta Medical
US Clinical & Technical Support Specialist
Remote, Remote
Responsable Affaires Réglementaires H/F
Marseille, Provence-Alpes-Côte d'Azur
